Abstract
Introduction We studied the levels and severity of anxiety caused by COVID-19 amongst frontline health-care workers (HCWs) in a tertiary care neurological hospital in Nepal, not assigned to manage COVID-19 cases.
Methods A cross-sectional study was conducted on 100 frontline Health Care Workers (HCWs) using a 10-point subjective assessment tool, the Anxiety Level Index (ALI), and the Zung Self Rating Anxiety Score (SAS), to assess the level of anxiety regarding COVID-19.
Results On ALI 55% of HCW were found to have marked severe anxiety (6-9), however, on SAS 44% of HCW’s reported anxiety. The majority HCW’s were female (n=78) with nurses forming 62% of the sample size. The mean age (±SD) was 26.8 years (± 8.17). Factors associated with significantly higher levels of anxiety regarding COVID-19 on ALI were age (p=0.002), sex (p=0.001), receiving regular COVID-19 updates via social media (p=0.011) and a high frequency of checking for COVID-19 information authenticity (p=0.039). Work experience (p=0.026) and frequency of checking for information authenticity (p=0.029) were factors found to increase SAS measured anxiety and were found to be associated with significantly higher levels of anxiety. Multivariate logistic regression analysis showed that respondents with work experience of ≤2 years were 0.380 (95% CI 0.158 to 0.910) times less likely to have anxiety than those with work experience of ≥2 years. Similarly, the odds of having anxiety among those who checked information authenticity less frequently was 0.377 (95% CI 0.153 to 0.931) times less than those who often did.
Conclusion The COVID-19 outbreak has caused a substantial impact on the mental health of frontline HCWs in a hospital not assigned to manage COVID-19 patients. Length of time of worked in healthcare and the frequency of checking for COVID-19-related information were significant predictors of anxiety.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UPD-NINAS institutional Review board approved the study. IRB Ref no 510/2020
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data would be made available upon appropriate request.
